Alyeska Investment Group
ANAC

Alyeska Investment Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Alyeska Investment Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-324,465
Closed -$10.5M – 677
2014
Q4 		$10.5M Buy
+324,465
New +$9.74M 0.18% 204
2013
Q3 		– Sell
-14,407
Closed -$81K – 416
2013
Q2 		$81K Buy
+14,407
New +$87.2K ﹤0.01% 265

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Alyeska Investment Group's ANAC Position: Q1 2015 in Review

Alyeska Investment Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2015, closing a stake of 324,465 shares — an estimated $10.5M sold.

Alyeska Investment Group first reported a position in ANAC in Q2 2013 and held it in 2 quarters. The position peaked at $10.5M in Q4 2014. 157 funds tracked by Wall St. Rank hold ANAC as of Q1 2015.

  • Alyeska Investment Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 324,465 ANACOR PHARMACEUTICALS INC COM shares in Q1 2015, an estimated $10.5M.
  • Alyeska Investment Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 2 quarters.
  • Alyeska Investment Group's ANACOR PHARMACEUTICALS INC COM position peaked at $10.5M in Q4 2014.
  • 157 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2015.

Based on Alyeska Investment Group's 13F filing for Q1 2015, filed 15 May 2015.